FOLH1 and posterior cortical atrophy: Finally, while many studies have been published on the role of radiolabeled PSMA-PET/CT in the recurrent PCa biochemical scenario, only a small number of studies explored its use in the primary staging of patients with intermediate-/high-risk PCa prior to therapy.28Notably, radiolabeled PSMA-PET imaging in combination with multiparametric MRI could enable a complete staging with increased accuracy and additional molecular information.29